BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
-
Mired in economic trouble, Bangladesh pins hopes on election boost
-
Chinese cash in jewellery at automated gold recyclers as prices soar
-
Israel to partially reopen Gaza's Rafah crossing
-
'Quiet assassin' Rybakina targets world number one after Melbourne win
-
Deportation raids drive Minneapolis immigrant family into hiding
-
Nvidia boss insists 'huge' investment in OpenAI on track
-
'Immortal' Indian comics keep up with changing times
-
With Trump mum, last US-Russia nuclear pact set to end
-
In Sudan's old port of Suakin, dreams of a tourism revival
-
Narco violence dominates as Costa Rica votes for president
-
Snowstorm barrels into southern US as blast of icy weather widens
-
LA Olympic chief 'deeply regrets' flirty Maxwell emails in Epstein files
-
Rose powers to commanding six-shot lead at Torrey Pines
-
Barca wasteful but beat Elche to extend Liga lead
-
Konate cut short compassionate leave to ease Liverpool injury crisis
-
Separatist attacks in Pakistan kill 33, dozens of militants dead
-
Dodgers manager Roberts says Ohtani won't pitch in Classic
-
Arsenal stretch Premier League lead as Chelsea, Liverpool stage comebacks
-
Korda defies cold and wind to lead LPGA opener
-
New head of US mission in Venezuela arrives as ties warm
-
Barca triumph at Elche to extend Liga lead
-
Ekitike, Wirtz give Liverpool sight of bright future in Newcastle win
-
West Indies 'tick boxes' in shortened T20 against South Africa
-
Chelsea have something 'special' says Rosenior
-
De Zerbi 'ready to go to war' to solve Marseille troubles
-
Hornets hold off Wemby's Spurs for sixth NBA win in a row
-
Moyes blasts killjoy booking after Everton's late leveller
-
Ex-prince Andrew again caught up in Epstein scandal
-
Bayern held at Hamburg to open door for Dortmund
-
Atletico stumble to draw at Levante, Villarreal held
-
Chelsea stage impressive fightback to beat West Ham
-
Arsenal stretch Premier League lead, Chelsea fightback breaks Hammers' hearts
-
Napoli edge Fiorentina as injury crisis deepens
-
How Lego got swept up in US-Mexico trade frictions
-
UK rights campaigner Tatchell arrested at pro-Palestinian protest
-
Iran says progress made towards US talks despite attack jitters
-
'Empowering': Ireland's first female sumo wrestler blazes a trail
-
US judge denies Minnesota bid to suspend immigration sweeps
-
Ukraine hit by mass power outages after 'technical malfunction'
-
AC Milan prolong France 'keeper Maignan deal by five years
-
Arteta hails Arsenal's statement rout of Leeds
-
Marseille buckle as Paris FC battle back for draw
-
Protesters demand 'justice' one month after Swiss bar fire
-
Philadelphia's Paul George gets 25-game NBA drugs ban
-
La Rochelle suffer defeat after shock Atonio retirement
-
'It wasn't working': Canada province ends drug decriminalization
-
Kishan, Arshdeep star as India down New Zealand in T20 finale
-
Moreno bags brace but Villarreal held at Osasuna
-
Kramaric keeps in-form Hoffenheim rolling in Bundesliga
-
'Skimo': Adrenalin-packed sprint to make Olympic debut
NYSE - LSE
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14th, 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30th, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 877-545-0320 |
Teleconference International: Participant Access Code: | +1-973-528-0002 517720 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Sunday, February 14th, 2027 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 53245 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
D.Lopez--AT
